Trials / Sponsors / Shenzhen Kexing Pharmaceutical Co., Ltd.
Shenzhen Kexing Pharmaceutical Co., Ltd.
Network · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovasc Neovascular Age-Related Macular Degeneration (nAMD) | Phase 1 | 2026-02-12 |
| Recruiting | To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection Cancer Cachexia (CC), Cancer Cachexia, Cancer Cachexia Syndrome | Phase 1 | 2025-10-28 |
| Not Yet Recruiting | Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency Growth Hormone Deficiency in Children, Growth Hormone Deficiency (GHD), Growth Hormone | Phase 2 / Phase 3 | 2025-08-31 |
| Unknown | Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19 COVID-19 | Phase 3 | 2023-05-13 |
| Completed | Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19 COVID-19 | Phase 2 | 2022-12-08 |
| Completed | A Phase I Study of SHEN26 Capsule in Healthy Participants Healthy Participants | Phase 1 | 2022-08-08 |